Page last updated: 2024-08-18

cdaa and lubiprostone

cdaa has been researched along with lubiprostone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Akahane, T; Enomoto, M; Fujimoto, Y; Fujinaga, Y; Kaji, K; Kawaratani, H; Murata, K; Namisaki, T; Nishimura, N; Takaya, H; Takeda, S; Tsuji, Y; Yoshiji, H	1

Other Studies

1 other study(ies) available for cdaa and lubiprostone

Article	Year
Rifaximin and lubiprostone mitigate liver fibrosis development by repairing gut barrier function in diet-induced rat steatohepatitis. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2022, Volume: 54, Issue:10 Topics: Acetamides; Amino Acids; Animals; Caco-2 Cells; Chloride Channels; Choline; Diet; Humans; Lipopolysaccharides; Liver; Liver Cirrhosis; Lubiprostone; Neuraminidase; Non-alcoholic Fatty Liver Disease; Pregnane X Receptor; Rats; Rats, Inbred F344; Rifaximin; Tight Junction Proteins; Toll-Like Receptor 4	2022

Article

Year

Rifaximin and lubiprostone mitigate liver fibrosis development by repairing gut barrier function in diet-induced rat steatohepatitis.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2022, Volume: 54, Issue:10

Topics: Acetamides; Amino Acids; Animals; Caco-2 Cells; Chloride Channels; Choline; Diet; Humans; Lipopolysaccharides; Liver; Liver Cirrhosis; Lubiprostone; Neuraminidase; Non-alcoholic Fatty Liver Disease; Pregnane X Receptor; Rats; Rats, Inbred F344; Rifaximin; Tight Junction Proteins; Toll-Like Receptor 4

2022